MIC Capital Management UK LLP

In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), MIC Capital Management UK LLP reported 14 stock positions worth $706.3 million. Its top holding was Endeavor Group Hold Class A (EDR) at 37.8% of the portfolio, followed by Hayward (HAYW, 21.6%) and Recursion Pharmaceuticals-A (RXRX, 9.2%). Compared with Q3 2024, it sold out of 1, added to 1 and reduced 1. The biggest buy was Recursion Pharmaceuticals-A (RXRX, shares +14%) and the biggest sale Hayward (HAYW, shares −15%).

Most Recent 13F
Q2 2026
Location
LONDON, X0
CIK
0001889830
Portfolio Value
$706.3M (Q4 2024)
SEC Filing
0001085146-25-001664 ↗ filed Feb 14, 2025

Holdings Value

0$200.0M$400.0M$600.0M$800.0M Q1 2024: $526.5M Q1 2024 Q2 2024: $460.0M Q2 2024 Q3 2024: $720.1M Q3 2024 Q4 2024: $706.3M $706.3M Q4 2024 Q1 2025: $490.8M Q1 2025 Q2 2025: $509.3M Q2 2025 Q3 2025: $500.3M Q3 2025 Q4 2025: $441.3M Q4 2025 Q1 2026: $352.5M Q1 2026 Q2 2026: $394.3M Q2 2026

Holdings 14 stocks · $706.3M

EDR Endeavor Group Hold Class A 37.82% 8,536,456 $267.1M No change
HAYW Hayward Holdings Inc. 21.64% 9,997,545 $152.9M Reduce -15.0%
RXRX Recursion Pharmaceuticals-A 9.23% 9,644,033 $65.2M Add +14.1%
NMRA Neumora Therapeutics Inc. 6.69% 4,460,700 $47.3M No change
CPNG Coupang Inc. 4.40% 1,412,946 $31.1M No change
QSR Restaurant Brands Intern 3.56% 386,203 $25.2M No change
GRAB Grab Holdings Ltd. Class A 3.34% 5,000,000 $23.6M No change
RVMD Revolution Medicines Inc. 3.15% 508,569 $22.2M No change
META Meta Platforms Inc. Class A 2.76% 33,300 $19.5M No change
SRAD Sportradar Group AG-A 2.27% 925,926 $16.1M No change
MNDY Monday.com Ltd. 2.20% 66,000 $15.5M No change
BABA Alibaba Group Holding-SP ADR 1.80% 150,000 $12.7M No change
ACHR Archer Aviation Inc. Class A 0.97% 700,000 $6.8M No change
LYEL Lyell Immunopharma Inc. 0.16% 1,740,569 $1.1M No change

Portfolio Sells Q3 2024 → Q4 2024

HAYW Hayward Holdings Inc. Reduce -15.0% 21.64% −3.42
EXAI Exscientia Ltd. Sold out 0.00% −1.05

Portfolio Buys Q3 2024 → Q4 2024

RXRX Recursion Pharmaceuticals-A Add +14.1% 9.23% +1.50

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 16$394.3MHAYW, RVMD, RXRX, QSR, CPNG
Q1 2026 14$352.5MHAYW, RVMD, KLAR, RXRX, QSR
Q4 2025 13$441.3MHAYW, KLAR, RVMD, RXRX, CPNG
Q3 2025 13$500.3MHAYW, KLAR, RXRX, CPNG, GRAB
Q2 2025 13$509.3MHAYW, MTSR, RXRX, CPNG, QSR
Q1 2025 14$490.8MHAYW, MTSR, RXRX, CPNG, QSR
Q4 2024 14$706.3MEDR, HAYW, RXRX, NMRA, CPNG
Q3 2024 15$720.1MEDR, HAYW, NMRA, RXRX, CPNG
Q2 2024 12$460.0MEDR, RXRX, NMRA, CPNG, QSR
Q1 2024 16$526.5MEDR, RXRX, NMRA, QSR, CPNG